PharVision Advisers’s Paymentus PAY Stock Holding History

PharVision Advisers’s Portfolio PAY Stock Details PAY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-7,414	Closed	-$234K	–	496
2025 Q4	$234K	Buy	+7,414	New	+$242K	0.12%	430

Other funds holding PAY

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $22.8B AUM 25.09% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

NCGI

Next Century Growth Investors Plymouth, Minnesota $1.89B AUM 151.53% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

PharVision Advisers's PAY Position: Q1 2026 in Review

PharVision Advisers sold out of Paymentus (PAY) in Q1 2026, closing a stake of 7,414 shares — an estimated $234K sold.

PharVision Advisers first reported a position in PAY in Q4 2025 and held it in 1 quarter. The position peaked at $234K in Q4 2025. 189 funds tracked by Wall St. Rank hold PAY as of Q1 2026.

PharVision Advisers reported no remaining Paymentus position as of Q1 2026 after selling out during the quarter.
PharVision Advisers sold 7,414 Paymentus shares in Q1 2026, an estimated $234K.
PharVision Advisers first reported a position in Paymentus in Q4 2025 and held it in 1 quarter.
PharVision Advisers's Paymentus position peaked at $234K in Q4 2025.
189 funds tracked by Wall St. Rank held Paymentus as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.